Page last updated: 2024-08-26

mci 9038 and Congenital Thrombotic Thrombocytopenic Purpura

mci 9038 has been researched along with Congenital Thrombotic Thrombocytopenic Purpura in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benken, ST; Kim, KS; Mucksavage, JJ; Tesoro, EP1

Other Studies

1 other study(ies) available for mci 9038 and Congenital Thrombotic Thrombocytopenic Purpura

ArticleYear
Treatment outcomes of heparin-induced thrombocytopenia in subarachnoid hemorrhage patients: a 4-year, retrospective single-center review.
    Neurocritical care, 2012, Volume: 17, Issue:2

    Topics: Adult; Aged; Antibodies, Anti-Idiotypic; Anticoagulants; Arginine; Female; Fondaparinux; Heparin; Humans; Immunoglobulin G; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Factor 4; Polysaccharides; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Subarachnoid Hemorrhage; Sulfonamides; Thrombocytopenia; Treatment Outcome

2012